Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;115:743-751
Published online before print January 29, 2007, doi: 10.1161/CIRCULATIONAHA.106.645499
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
115/6/743    most recent
CIRCULATIONAHA.106.645499v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peng, J.
Right arrow Articles by Gotthardt, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peng, J.
Right arrow Articles by Gotthardt, M.
Right arrowPubmed/NCBI databases
*Protein
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
*TAMOXIFEN
Related Collections
Right arrow Contractile function
Right arrow Animal models of human disease
Right arrow Genetically altered mice
Right arrow Heart failure - basic studies

(Circulation. 2007;115:743-751.)
© 2007 American Heart Association, Inc.


Molecular Cardiology

Cardiac Hypertrophy and Reduced Contractility in Hearts Deficient in the Titin Kinase Region

Jun Peng, MD, PhD; Katy Raddatz, MS; Jeffery D. Molkentin, PhD; Yiming Wu, MD, PhD; Siegfried Labeit, MD; Henk Granzier, PhD; Michael Gotthardt, MD

From the Department of Veterinary and Comparative Anatomy, Pharmacology, and Physiology, Washington State University, Pullman (J.P, Y.W., H.G., M.G.); Neuromuscular and Cardiovascular Cell Biology, Max-Delbrück Center for Molecular Medicine, Berlin, Germany (K.R., M.G.); Division of Molecular Cardiovascular Biology, Department of Pediatrics, Children’s Hospital Medical Center, Cincinnati, Ohio (J.M.); and Department of Anesthesiology, Mannheim University, Mannheim, Germany (S.L.).

Correspondence to Michael Gotthardt, VCAPP, Washington State University, Wegner Hall, Room 205, Pullman, WA 99164–6520 (e-mail gotthard{at}vetmed.wsu.edu); or Max-Delbrück-Center for Molecular Medicine Berlin-Buch, Robert Rössle Str 10, 13125 Berlin, Germany (e-mail gotthardt@mdc-berlin.de).

Received June 13, 2006; accepted November 20, 2006.

Background— Titin is a giant protein crucial for the assembly and elasticity of the sarcomere. Recently, titin has been linked to signal transduction through its kinase domain, which has been proposed to sense mechanical load. We developed a knockout in which expression of M-line–deficient titin can be induced in adult mice and investigated the role of the titin kinase region in cardiac function.

Methods and Results— Isolated heart experiments revealed that in titin M-line–deficient mice, the contractile response to ß-adrenergic agonists and extracellular calcium is reduced. However, the Ca2+ sensitivity and cooperativity of activation of skinned cardiac muscle were unchanged. In knockout mice, calcium transients showed a reduced rate of calcium uptake, and expression analysis showed reduced levels of calmodulin, phospholamban, and SERCA2. Ultimately, knockout mice developed cardiac hypertrophy and heart failure, which involves protein kinase C signal transduction but not the mitogen-activated protein kinase pathway.

Conclusions— The titin kinase region emerges as a regulator of contractile function through effects on calcium handling and hypertrophy through protein kinase signal transduction. These novel functions of titin might provide a rationale for future therapeutic approaches to attenuate or reverse symptoms of heart failure.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
A. Kontrogianni-Konstantopoulos, M. A. Ackermann, A. L. Bowman, S. V. Yap, and R. J. Bloch
Muscle Giants: Molecular Scaffolds in Sarcomerogenesis
Physiol Rev, October 1, 2009; 89(4): 1217 - 1267.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Borbely, I. Falcao-Pires, L. van Heerebeek, N. Hamdani, I. Edes, C. Gavina, A. F. Leite-Moreira, J. G.F. Bronzwaer, Z. Papp, J. van der Velden, et al.
Hypophosphorylation of the Stiff N2B Titin Isoform Raises Cardiomyocyte Resting Tension in Failing Human Myocardium
Circ. Res., March 27, 2009; 104(6): 780 - 786.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. R. Cunha and P. J. Mohler
Obscurin Targets Ankyrin-B and Protein Phosphatase 2A to the Cardiac M-line
J. Biol. Chem., November 14, 2008; 283(46): 31968 - 31980.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
U. Lisewski, Y. Shi, U. Wrackmeyer, R. Fischer, C. Chen, A. Schirdewan, R. Juttner, F. Rathjen, W. Poller, M. H. Radke, et al.
The tight junction protein CAR regulates cardiac conduction and cell-cell communication
J. Exp. Med., September 29, 2008; 205(10): 2369 - 2379.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A. Fukuzawa, S. Lange, M. Holt, A. Vihola, V. Carmignac, A. Ferreiro, B. Udd, and M. Gautel
Interactions with titin and myomesin target obscurin and obscurin-like 1 to the M-band - implications for hereditary myopathies
J. Cell Sci., June 1, 2008; 121(11): 1841 - 1851.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. K. Slinker and S. A. Glantz
Multiple Linear Regression: Accounting for Multiple Simultaneous Determinants of a Continuous Dependent Variable
Circulation, April 1, 2008; 117(13): 1732 - 1737.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
W. A. Linke
Sense and stretchability: The role of titin and titin-associated proteins in myocardial stress-sensing and mechanical dysfunction
Cardiovasc Res, March 1, 2008; 77(4): 637 - 648.
[Abstract] [Full Text] [PDF]